Similar articles for PMID: 37929901

Year	Number of Results
2016	1
2018	1
2019	4
2020	25
2021	28
2022	24
2023	19
2024	6

1

Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors.

Liu Q, Li L, Qin W, Chao T. Liu Q, et al. Cancer Biol Med. 2023 Nov 6;20(11):856-68. doi: 10.20892/j.issn.2095-3941.2023.0281. Cancer Biol Med. 2023. PMID: 37929901 Free PMC article. Review.

2

The RANK-RANKL axis: an opportunity for drug repurposing in cancer?

Peters S, Clézardin P, Márquez-Rodas I, Niepel D, Gedye C. Peters S, et al. Clin Transl Oncol. 2019 Aug;21(8):977-991. doi: 10.1007/s12094-018-02023-5. Epub 2019 Jan 17. Clin Transl Oncol. 2019. PMID: 30656607 Free article. Review.

3

Therapeutic Repurposing of Biguanides in Cancer.

Zhao H, Swanson KD, Zheng B. Zhao H, et al. Trends Cancer. 2021 Aug;7(8):714-730. doi: 10.1016/j.trecan.2021.03.001. Epub 2021 Apr 14. Trends Cancer. 2021. PMID: 33865798 Free PMC article. Review.

4

Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy.

Tschernia NP, Gulley JL. Tschernia NP, et al. BioDrugs. 2022 Mar;36(2):153-180. doi: 10.1007/s40259-022-00521-1. Epub 2022 Mar 30. BioDrugs. 2022. PMID: 35353346 Free PMC article. Review.

5

PD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II Study.

Kong Y, Zhao X, Xu M, Pan J, Ma Y, Zou L, Peng Q, Zhang J, Su C, Xu Z, Zhou W, Peng Y, Yang J, Zhou C, Li Y, Guo Q, Chen G, Wu H, Xing P, Zhang L. Kong Y, et al. Front Immunol. 2022 Jul 8;13:952066. doi: 10.3389/fimmu.2022.952066. eCollection 2022. Front Immunol. 2022. PMID: 35874780 Free PMC article. Clinical Trial.

6

Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.

Xing R, Gao J, Cui Q, Wang Q. Xing R, et al. Front Immunol. 2021 Nov 26;12:783236. doi: 10.3389/fimmu.2021.783236. eCollection 2021. Front Immunol. 2021. PMID: 34899747 Free PMC article. Review.

7

Combining immune checkpoint inhibitors with denosumab: a new era in repurposing denosumab in oncology?

V Deligiorgi M, Panayiotidis MI, Trafalis DT. V Deligiorgi M, et al. J BUON. 2020 Jan-Feb;25(1):1-14. J BUON. 2020. PMID: 32277609 Review.

8

Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.

Mohi-Ud-Din R, Chawla A, Sharma P, Mir PA, Potoo FH, Reiner Ž, Reiner I, Ateşşahin DA, Sharifi-Rad J, Mir RH, Calina D. Mohi-Ud-Din R, et al. Eur J Med Res. 2023 Sep 14;28(1):345. doi: 10.1186/s40001-023-01275-4. Eur J Med Res. 2023. PMID: 37710280 Free PMC article. Review.

9

Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report.

Liu Z, Wang F, Zhang Y, Lu J, Yang Y. Liu Z, et al. Front Immunol. 2024 Feb 1;15:1321946. doi: 10.3389/fimmu.2024.1321946. eCollection 2024. Front Immunol. 2024. PMID: 38361930 Free PMC article.

10

Systemic treatments for metastatic cutaneous melanoma.

Pasquali S, Hadjinicolaou AV, Chiarion Sileni V, Rossi CR, Mocellin S. Pasquali S, et al. Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2. Cochrane Database Syst Rev. 2018. PMID: 29405038 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year